SynthesisThe oncologist2025

Incidence and risk of hypertension and proteinuria in cancer patients treated with lenvatinib: a systematic review and meta-analysis.

Yuma Shibutani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.